U.S. Pharmaceutical Third-party Logistics Services Market (2025 - 2030) Size, Share & Trends Analysis Report By Product Type (Branded, Cell Therapy, Biosimilar), By Temperature (Ambient, Refrigerated), By Therapeutic Area, By Manufacturer Size, By Service, And Segment Forecasts

Market Segmentation

• U.S. Pharmaceutical Third Party Logistics (3PL) Services Product Type Outlook (Revenue in USD Million, 2018 - 2030)
  • Branded
  • Generic
  • Biosimilar
  • Vaccine
  • Cell Therapy
  • Gene Therapy
  • Others
• U.S. Pharmaceutical Third Party Logistics (3PL) Services Temperature Outlook (Revenue in USD Million, 2018 - 2030)
  • Ambient
  • Refrigerated
  • Frozen
  • Ultra-frozen/Deep-Frozen
  • Cryogenic
• U.S. Pharmaceutical Third Party Logistics (3PL) Services Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurology
  • Diabetes
  • Nephrology
  • Rheumatology
  • Allergy/Asthma
  • Gastroenterology
  • Ophthalmology
  • Others
• U.S. Pharmaceutical Third Party Logistics (3PL) Services Manufacturer Size Outlook (Revenue in USD Million, 2018 - 2030)
  • Large
  • Medium
  • Small
• U.S. Pharmaceutical Third Party Logistics (3PL) Services Service Size Outlook (Revenue in USD Million, 2018 - 2030)
  • Storage and Shipping
  • Order-to-cash
  • Title Model
  • DSCSA and Serialization Services
  • Pharmaceutical Sampling
  • Others
• U.S. Pharmaceutical Third Party Logistics (3PL) Services Country Outlook (Revenue, USD Million, 2018 - 2030)
  • U.S.
    • U.S. Product Type Outlook (Revenue in USD Million, 2018 - 2030)
      • Branded
      • Generic
      • Biosimilar
      • Vaccine
      • Cell Therapy
      • Gene Therapy
      • Others
    • U.S. Temperature Outlook (Revenue in USD Million, 2018 - 2030)
      • Ambient
      • Refrigerated
      • Frozen
      • Ultra-frozen/Deep-Frozen
      • Cryogenic
    • U.S. Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      • Oncology
      • Cardiovascular Diseases
      • Infectious Diseases
      • Neurology
      • Diabetes
      • Nephrology
      • Rheumatology
      • Allergy/Asthma
      • Gastroenterology
      • Ophthalmology
      • Others
    • U.S. Manufacturer Size Outlook (Revenue in USD Million, 2018 - 2030)
      • Large
      • Medium
      • Small
    • U.S. Service Outlook (Revenue in USD Million, 2018 - 2030)
      • Storage and Shipping
      • Order-to-cash
      • Title Model
      • DSCSA and Serialization Services
      • Pharmaceutical Sampling
      • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Country market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Country market size and forecast for application segments up to 2030
• Company financial performance